Results 91 to 100 of about 19,083 (252)

Autoantibodies to Joint‐Related Peptides Are Associated With Onset of Rheumatoid Arthritis in Presymptomatic Seronegative Individuals

Arthritis &Rheumatology, EarlyView.
Objective To identify autoantibodies in presymptomatic individuals that associate with the onset of rheumatoid arthritis (RA) and to distinguish early RA from osteoarthritis (OA), particularly in individuals lacking classic RA serologic markers. Methods We analyzed serum and plasma from three cohorts: presymptomatic individuals who later developed RA ...
Outi Sareila, Linda Johansson, Anders Lundquist, Monica Leu Agelii, Lei Cheng, Yibo He, Erik Lönnblom, Maria Andersson, Jan Kihlberg, Anders Esberg, Inger Gjertsson, Rikard Holmdahl, Solbritt Rantapää‐Dahlqvist   +12 more
wiley   +1 more source

Drug use monthly measured by DDD/1000P in (C01) Cardiac therapy, (C02) Antihypertensives, (C07) Beta-blocking agents, (M01) Antiinflammatory and antirheumatic products, and (M04) Antigout preparations from January 2016 to December 2022.

Drug use monthly measured by DDD/1000P in (C01) Cardiac therapy, (C02) Antihypertensives, (C07) Beta-blocking agents, (M01) Antiinflammatory and antirheumatic products, and (M04) Antigout preparations from January 2016 to December 2022.
Nguyen Dang Tu Le (10024031), Minh-Anh Le-Dang (17817332), Hien Pham Thu (17817341), Luyen Pham Dinh (17817335), Dinh Thanh Le (17817344), Hai-Yen Nguyen-Thi (9963037), Danh Le Ngoc (17817338)   +6 more
core   +1 more source

Rationales for discontinuation of disease-modifying antirheumatic drugs, biologic agents, and tofacitinib in rheumatoid arthritis

, 2018
Objective: to analyze the reasons for discontinuation of traditional disease-modifying antirheumatic drugs (tDMARDs), biologic agents (BAs), and tofacitinib (TOFA) in patients with rheumatoid arthritis (RA) in real clinical practice.Patients and methods.
K. S. Nurbaeva, K. M. Mikhailov, Yu. V. Muraviev, A. V. Rozov, L. A. Muravieva, N. V. Muravieva, A. V. Alexeeva, G. I. Gridneva   +7 more
core   +1 more source

Determinants of Difficult‐to‐Manage and Treatment‐Refractory Axial Spondyloarthritis: A Cross‐Sectional Analysis Within a Longitudinal Cohort

Arthritis &Rheumatology, EarlyView.
Objective The purpose of this study was to estimate the prevalence of difficult‐to‐manage (D2M) and treatment‐refractory (TR) axial spondyloarthritis (axSpA) and to identify factors associated with D2M and TR disease in a longitudinal cohort. Methods We performed a cross‐sectional analysis on data from the Schroeder Arthritis Institute Spondylitis ...
Patricia Remalante‐Rayco, Laura Passalent, Tina Chim, Hannah Vijayan, Manal Alnasser, Zeynep Baskurt, Robert D. Inman, Nigil Haroon, Denis Poddubnyy   +8 more
wiley   +1 more source

Increasing the reporting of adverse drug reaction‐related hospitalizations using an ICD‐10‐based identification workflow: A multicentre study from Switzerland

British Journal of Clinical Pharmacology, EarlyView.
Background Reporting adverse drug reactions (ADRs) is essential for drug safety. In Switzerland, healthcare professionals are legally required to report serious and unlabelled ADRs, yet under‐reporting remains widespread. We tested a novel method to increase reporting of ADR‐related hospitalizations.
Georgia Anita Weber, Sophie‐Charlotte Bartel, Michael Boch, Christoph Rosen, Michael Bodmer, Balthasar Luzius Hug, Thomas Stammschulte, Patrick E. Beeler   +7 more
wiley   +1 more source

Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy

, 2011
Given the availability of novel biologic agents for the treatment of rheumatoid arthritis (RA), various national scientific societies have developed specific recommendations in order to assist rheumatologists in prescribing these drugs.
M. Cutolo, Pipitone, Nicolo', Valesini G., F. Atzeni, Cutolo, Maurizio, Bugatti S., N. Pipitone, S. Guiducci, Montecucco C., Atzeni F., Gremese E., Bugatti, Serena, Sarzi Puttini P., Conti F., Caporali, Roberto, G. Zampogna, Salvarani C., Alivernini S., Pipitone N., Zampogna G., Matucci Cerinic, Marco, B. Seriolo, Ferraccioli, Gianfranco, Atzeni, Fabiola, Sarzi Puttini, Piercarlo, Zampogna, Giuseppe, Italian Society For Rheumatology, C. Salvarani, C. Montecucco, Gremese, Elisa, Scrivo R., P. Sarzi Puttini, Valesini, Guido, SALVARANI, CARLO, Conti, Francesco, Ferraccioli G., Caporali R., Alivernini, Stefano, S. Bugatti, Guiducci S., Seriolo B., Conti, Fabrizio, G. Ferraccioli, Scrivo, Rossana, Montecucco, Carlomaurizio, Cutolo M., Matucci Cerinic M., Seriolo, Bruno, Sarzi-Puttini P., S. Alivernini, E. Gremese, R. Caporali, Guiducci, Serena, M. Matucci Cerinic, Matucci-Cerinic M.   +54 more
core  

Perioperative management of antirheumatic therapy [PDF]

, 2011
RESUMEN: Cuando se somete a cirugía a los pacientes con enfermedades reumáticas, una decisión difícil es si se suspende o no la medicación antirreumática durante el período perioperatorio. La mayor dificultad reside en lograr un equilibrio entre mantener
Ramírez Gómez, Luis Alberto, González Naranjo, Luis Alonso   +1 more
core  

Ten‐Year Public Expenditure Savings Associated with TNF Inhibitor Biosimilars under Australia's Pharmaceutical Benefits Scheme

Clinical Pharmacology &Therapeutics, EarlyView.
Biologic therapies are a major and growing driver of pharmaceutical expenditure globally, with tumor necrosis factor (TNF) inhibitors among the most widely used and costly biologics. In Australia, these therapies are funded through the Pharmaceutical Benefits Scheme (PBS), where biosimilars offer lower cost alternatives; however, the long‐term public ...
Chin Hang Yiu, Bella D. Ianni, Richard O. Day, Jacques Raubenheimer, Christine Y. Lu   +4 more
wiley   +1 more source

Are there antirheumatic drugs which could increase the synthesis of prostaglandins?

, 1977
The isolated guinea pig ileum was used to test the agonists to induce smooth muscle contractions in the presence of classical antirheumatic agents. It has been shown that colchicine and vinblastine which are known to increase prostaglandin synthesis can ...
Fontaine, Jeanine, Famaey, Jean Pierre, Reuse, Joannes   +2 more
core  

Advanced Molecular Imaging Probes for Skeletal Diseases: Current Progress and Future Perspectives

iRADIOLOGY, EarlyView.
This review summarizes the potential molecular imaging techniques and probes for common orthopedic diseases, such as trauma, infection, metabolism, tumor, joint, spine and other fields, aiming to provide a basis for the development of a new generation of molecular imaging probes.
Shuo Guo, Yuling Cui, Zhiye Fan, Chenxin Jiang, Bowen Fu, Guangbin Cui, Yanli He   +6 more
wiley   +1 more source